Lingtong Meng
Nanjing Normal University(CN)Beijing Emergency Medical Center(CN)
Publications by Year
Research Areas
Nanoplatforms for cancer theranostics, Cancer, Hypoxia, and Metabolism, Nanoparticle-Based Drug Delivery, Cancer Research and Treatments, Liver Disease Diagnosis and Treatment
Most-Cited Works
- → Tumor Oxygenation and Hypoxia Inducible Factor-1 Functional Inhibition via a Reactive Oxygen Species Responsive Nanoplatform for Enhancing Radiation Therapy and Abscopal Effects(2018)264 cited
- → Facile Deposition of Manganese Dioxide to Albumin-Bound Paclitaxel Nanoparticles for Modulation of Hypoxic Tumor Microenvironment To Improve Chemoradiation Therapy(2017)68 cited
- → Enhanced tolerance and antitumor efficacy by docetaxel-loaded albumin nanoparticles(2015)57 cited
- → Targeted Regulation of Blood–Brain Barrier for Enhanced Therapeutic Efficiency of Hypoxia-Modifier Nanoparticles and Immune Checkpoint Blockade Antibodies for Glioblastoma(2021)56 cited
- → Enhanced hepatic targeting, biodistribution and antifibrotic efficacy of tanshinone IIA loaded globin nanoparticles(2015)41 cited
- → Bifunctional liposomes reduce the chemotherapy resistance of doxorubicin induced by reactive oxygen species(2019)32 cited
- → New application of an old drug proparacaine in treating epilepsy via liposomal hydrogel formulation(2021)30 cited
- → GRPr-mediated photothermal and thermodynamic dual-therapy for prostate cancer with synergistic anti-apoptosis mechanism(2021)26 cited
- → Enhancement of radiotherapy efficacy by pleiotropic liposomes encapsulated paclitaxel and perfluorotributylamine(2017)25 cited
- → Oxygen-rich chemotherapyviamodified Abraxane to inhibit the growth and metastasis of triple-negative breast cancer(2018)25 cited